Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SRTS |
---|---|---|
09:32 ET | 662 | 5.8 |
09:41 ET | 2633 | 5.89 |
09:43 ET | 795 | 5.9 |
09:45 ET | 800 | 5.9 |
09:48 ET | 500 | 5.88 |
09:54 ET | 2414 | 5.8972 |
09:59 ET | 1050 | 5.9071 |
10:14 ET | 1559 | 5.93 |
10:26 ET | 3000 | 5.9299 |
10:30 ET | 614 | 5.93 |
10:33 ET | 200 | 5.91 |
10:39 ET | 100 | 5.8867 |
10:46 ET | 100 | 5.905 |
10:51 ET | 1346 | 5.885 |
11:00 ET | 900 | 5.8372 |
11:04 ET | 100 | 5.8175 |
11:11 ET | 121 | 5.835 |
11:20 ET | 1140 | 5.785 |
11:24 ET | 100 | 5.76 |
11:29 ET | 500 | 5.7664 |
11:31 ET | 400 | 5.7838 |
11:33 ET | 2100 | 5.81 |
11:36 ET | 300 | 5.8399 |
11:45 ET | 3881 | 5.79 |
11:49 ET | 100 | 5.77 |
11:54 ET | 1053 | 5.86 |
11:58 ET | 300 | 5.92 |
12:00 ET | 800 | 5.9 |
12:02 ET | 392 | 5.91 |
12:03 ET | 200 | 5.8601 |
12:05 ET | 502 | 5.89 |
12:16 ET | 100 | 5.89 |
12:20 ET | 3500 | 5.87 |
12:27 ET | 200 | 5.83 |
12:43 ET | 411 | 5.8109 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Sensus Healthcare Inc | 94.2M | 14.3x | --- |
Rapid Micro Biosystems Inc | 38.5M | -0.8x | --- |
Stereotaxis Inc | 168.5M | -7.7x | --- |
Cytosorbents Corp | 77.3M | -2.6x | --- |
ICAD Inc | 42.9M | -9.7x | --- |
Hyperfine Inc | 76.3M | -1.8x | --- |
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $94.2M |
---|---|
Revenue (TTM) | $36.4M |
Shares Outstanding | 16.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $0.41 |
Book Value | $2.98 |
P/E Ratio | 14.3x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 23.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.